428 related articles for article (PubMed ID: 30171718)
1. PNPLA3 variant M148 causes resistance to starvation-mediated lipid droplet autophagy in human hepatocytes.
Negoita F; Blomdahl J; Wasserstrom S; Winberg ME; Osmark P; Larsson S; Stenkula KG; Ekstedt M; Kechagias S; Holm C; Jones HA
J Cell Biochem; 2019 Jan; 120(1):343-356. PubMed ID: 30171718
[TBL] [Abstract][Full Text] [Related]
2. Autophagy and Lipid Droplets in the Liver.
Martinez-Lopez N; Singh R
Annu Rev Nutr; 2015; 35():215-37. PubMed ID: 26076903
[TBL] [Abstract][Full Text] [Related]
3. The Propensity of the Human Liver to Form Large Lipid Droplets Is Associated with PNPLA3 Polymorphism, Reduced INSIG1 and NPC1L1 Expression and Increased Fibrogenetic Capacity.
Ferri F; Carotti S; Carpino G; Mischitelli M; Cantafora A; Molinaro A; Argenziano ME; Parisse S; Corsi A; Riminucci M; Lai Q; Mennini G; Spadetta G; Pugliese F; Rossi M; Morini S; Gaudio E; Ginanni Corradini S
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34198853
[TBL] [Abstract][Full Text] [Related]
4. Oleic acid-induced defective autolysosome shows impaired lipid degradation.
Lee DH; Ahn J; Jang YJ; Ha TY; Jung CH
Biochem Biophys Res Commun; 2019 Jun; 513(3):553-559. PubMed ID: 30981498
[TBL] [Abstract][Full Text] [Related]
5. The PNPLA3 I148M variant promotes lipid-induced hepatocyte secretion of CXC chemokines establishing a tumorigenic milieu.
Nischalke HD; Lutz P; Bartok E; Krämer B; Langhans B; Frizler R; Berg T; Hampe J; Buch S; Datz C; Stickel F; Hartmann G; Strassburg CP; Nattermann J; Spengler U
J Mol Med (Berl); 2019 Nov; 97(11):1589-1600. PubMed ID: 31637480
[TBL] [Abstract][Full Text] [Related]
6. PNPLA3-I148M: a problem of plenty in non-alcoholic fatty liver disease.
Basu Ray S
Adipocyte; 2019 Dec; 8(1):201-208. PubMed ID: 31062641
[TBL] [Abstract][Full Text] [Related]
7. PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells.
Pirazzi C; Valenti L; Motta BM; Pingitore P; Hedfalk K; Mancina RM; Burza MA; Indiveri C; Ferro Y; Montalcini T; Maglio C; Dongiovanni P; Fargion S; Rametta R; Pujia A; Andersson L; Ghosal S; Levin M; Wiklund O; Iacovino M; Borén J; Romeo S
Hum Mol Genet; 2014 Aug; 23(15):4077-85. PubMed ID: 24670599
[TBL] [Abstract][Full Text] [Related]
8. Formononetin alleviates hepatic steatosis by facilitating TFEB-mediated lysosome biogenesis and lipophagy.
Wang Y; Zhao H; Li X; Wang Q; Yan M; Zhang H; Zhao T; Zhang N; Zhang P; Peng L; Li P
J Nutr Biochem; 2019 Nov; 73():108214. PubMed ID: 31520816
[TBL] [Abstract][Full Text] [Related]
9. Shifts in dietary carbohydrate-lipid exposure regulate expression of the non-alcoholic fatty liver disease-associated gene PNPLA3/adiponutrin in mouse liver and HepG2 human liver cells.
Hao L; Ito K; Huang KH; Sae-tan S; Lambert JD; Ross AC
Metabolism; 2014 Oct; 63(10):1352-62. PubMed ID: 25060692
[TBL] [Abstract][Full Text] [Related]
10. The rs2294918 E434K variant modulates patatin-like phospholipase domain-containing 3 expression and liver damage.
Donati B; Motta BM; Pingitore P; Meroni M; Pietrelli A; Alisi A; Petta S; Xing C; Dongiovanni P; del Menico B; Rametta R; Mancina RM; Badiali S; Fracanzani AL; Craxì A; Fargion S; Nobili V; Romeo S; Valenti L
Hepatology; 2016 Mar; 63(3):787-98. PubMed ID: 26605757
[TBL] [Abstract][Full Text] [Related]
11. Distinct regulation of adiponutrin/PNPLA3 gene expression by the transcription factors ChREBP and SREBP1c in mouse and human hepatocytes.
Dubuquoy C; Robichon C; Lasnier F; Langlois C; Dugail I; Foufelle F; Girard J; Burnol AF; Postic C; Moldes M
J Hepatol; 2011 Jul; 55(1):145-53. PubMed ID: 21145868
[TBL] [Abstract][Full Text] [Related]
12. ATGL Promotes Autophagy/Lipophagy via SIRT1 to Control Hepatic Lipid Droplet Catabolism.
Sathyanarayan A; Mashek MT; Mashek DG
Cell Rep; 2017 Apr; 19(1):1-9. PubMed ID: 28380348
[TBL] [Abstract][Full Text] [Related]
13. PNPLA3 Expression Is Related to Liver Steatosis in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease.
Aragonès G; Auguet T; Armengol S; Berlanga A; Guiu-Jurado E; Aguilar C; Martínez S; Sabench F; Porras JA; Ruiz MD; Hernández M; Sirvent JJ; Del Castillo D; Richart C
Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27128907
[TBL] [Abstract][Full Text] [Related]
14. Impairment of lipophagy by PNPLA1 mutations causes lipid droplet accumulation in primary fibroblasts of Autosomal Recessive Congenital Ichthyosis patients.
Onal G; Kutlu O; Ozer E; Gozuacik D; Karaduman A; Dokmeci Emre S
J Dermatol Sci; 2019 Jan; 93(1):50-57. PubMed ID: 30655104
[TBL] [Abstract][Full Text] [Related]
15. PNPLA3 downregulation exacerbates the fibrotic response in human hepatic stellate cells.
Rady B; Nishio T; Dhar D; Liu X; Erion M; Kisseleva T; Brenner DA; Pocai A
PLoS One; 2021; 16(12):e0260721. PubMed ID: 34879108
[TBL] [Abstract][Full Text] [Related]
16. Ajugol enhances TFEB-mediated lysosome biogenesis and lipophagy to alleviate non-alcoholic fatty liver disease.
Zhang H; Lu J; Liu H; Guan L; Xu S; Wang Z; Qiu Y; Liu H; Peng L; Men X
Pharmacol Res; 2021 Dec; 174():105964. PubMed ID: 34732369
[TBL] [Abstract][Full Text] [Related]
17. Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis.
Smagris E; BasuRay S; Li J; Huang Y; Lai KM; Gromada J; Cohen JC; Hobbs HH
Hepatology; 2015 Jan; 61(1):108-18. PubMed ID: 24917523
[TBL] [Abstract][Full Text] [Related]
18. Naringin Protects against Non-Alcoholic Fatty Liver Disease by Promoting Autophagic Flux and Lipophagy.
Guan L; Guo L; Zhang H; Liu H; Zhou W; Zhai Y; Yan X; Men X; Peng L
Mol Nutr Food Res; 2024 Feb; 68(3):e2200812. PubMed ID: 38054638
[TBL] [Abstract][Full Text] [Related]
19. Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro.
Pirazzi C; Adiels M; Burza MA; Mancina RM; Levin M; Ståhlman M; Taskinen MR; Orho-Melander M; Perman J; Pujia A; Andersson L; Maglio C; Montalcini T; Wiklund O; Borén J; Romeo S
J Hepatol; 2012 Dec; 57(6):1276-82. PubMed ID: 22878467
[TBL] [Abstract][Full Text] [Related]
20. PNPLA3 p.I148M variant is associated with greater reduction of liver fat content after bariatric surgery.
Krawczyk M; Jiménez-Agüero R; Alustiza JM; Emparanza JI; Perugorria MJ; Bujanda L; Lammert F; Banales JM
Surg Obes Relat Dis; 2016 Dec; 12(10):1838-1846. PubMed ID: 27576208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
